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Jarid2 is part of the Polycomb Repressor complex 2
(PRC2) responsible for genome-wide H3K27me3
deposition. Unlike other PRC2-deficient embryonic
stem cells (ESCs), however, Jarid2-deficient ESCs
show a severe differentiation block, altered colony
morphology, and distinctive patterns of deregulated
gene expression. Here, we show that Jarid2/
ESCs express constitutively high levels of Nanog
but reduced PCP signaling components Wnt9a,
Prickle1, and Fzd2 and lowered b-catenin activity.
Depletion of Wnt9a/Prickle1/Fzd2 from wild-type
ESCs or overexpression of Nanog largely phenocop-
ies thesecellular defects. Co-culture of Jarid2/with
wild-type ESCs restores variable Nanog expression
andb-catenin activity and canpartially rescue the dif-
ferentiation block of mutant cells. In addition, we
show that ESCs lacking Jarid2 or Wnt9a/Prickle1/
Fzd2 or overexpressing Nanog induce multiple ICM
formationwhen injected intonormalE3.5blastocysts.
These data describe a previously unrecognized role
for Jarid2 in regulating a core pluripotency and Wnt/
PCP signaling circuit that is important for ESC differ-
entiation and for pre-implantation development.INTRODUCTION
Jarid2 (Jumonji, AT-rich interactive domain 2) is the founding
member of the Jumonji family of proteins that can demethylate
histones, although Jarid2 itself is unable to do so (Klose et al.,
2006; Landeira and Fisher, 2011). Jarid2 was discovered in
1995 as a regulator of neural development in a gene trap screenin mice (Takeuchi et al., 1995), and Jarid2 deficiency was later
shown to result in a range of phenotypes with variable severity
and onset with defects in heart and neural tube formation and hy-
poplasia of liver, spleen, and blood tissues (Jung et al., 2005;
Landeira and Fisher, 2011; Takeuchi et al., 2006). In humans,
mutations in Jarid2 have been linked to congenital defects
including nonsyndromic cleft lip, spina bifida, and congenital
heart abnormalities (Scapoli et al., 2010; Volcik et al., 2004),
and haploinsufficiency is linked to intellectual disability and brain
dysfunction including schizophrenia (Barøy et al., 2013; Celes-
tino-Soper et al., 2012; Pedrosa et al., 2007; Ramos et al.,
2012). At the cellular level, Jarid2 is known to inhibit myogenic
differentiation in mouse and human cells (Walters et al., 2014),
is important for the scheduled proliferation of epidermal stem
and progenitor cells (Mejetta et al., 2011), and is thought to input
into cell-cycle control by regulating cyclin D1 (Nakajima et al.,
2011; Toyoda et al., 2003). In embryonic stem cells (ESCs),
Jarid2 is particularly abundant and has been implicated as a
hub component of transcriptional networks that underpin plurip-
otency (Assou et al., 2009; Kim et al., 2008; Loh et al., 2006; Sun
et al., 2008; Zhou et al., 2007). ESCs lacking Jarid2 remain viable
and pluripotent but are unable to efficiently differentiate in culture
and show alterations in growth kinetics and in colony
morphology (Landeira et al., 2010; Li et al., 2010; Pasini et al.,
2010; Shen et al., 2009).
Jarid2 is a critical component of the Polycomb Repressor
complex 2 (PRC2), implicated in guiding the deposition of
H3K27me3 across the genome (Landeira et al., 2010; Li et al.,
2010; Pasini et al., 2010; Peng et al., 2009; Shen et al., 2009).
In ESCs, Jarid2 binds to a similar set of genomic sites as core
PRC2 components, such as Embryonic ectoderm development
(Eed), Suppressor of Zeste 12 (Suz12), and Enhancer of Zeste 2
(Ezh2) (Landeira et al., 2010; Li et al., 2010; Pasini et al., 2010;
Peng et al., 2009; Shen et al., 2009). In Drosophila, Jarid2 also
binds to sites that broadly overlap with other core PRC2 mem-
bers, albeit at slightly different levels and with some exceptionsCell Reports 12, 573–586, July 28, 2015 ª2015 The Authors 573
(Herz et al., 2012). Although these results support a role for
Jarid2 in PRC2 recruitment, in concert with co-factors such as
Aebp2, Pcl1, 2, 3, and esPRC2p48 (Hunkapiller et al., 2012;
Kalb et al., 2014; Kim et al., 2009; Li et al., 2010; Sarma et al.,
2008; Walker et al., 2010; Zhang et al., 2011), the consequence
of Jarid2 loss for H3K27me3 levels is unclear, as both increased
(Peng et al., 2009; Shen et al., 2009) and decreased H3K27me-
thylation have been reported (Landeira et al., 2010; Li et al.,
2010; Pasini et al., 2010). In addition, recent studies of X-inacti-
vation have shown that, while Jarid2 is necessary for efficient
PRC2 recruitment, Jarid2 binds to Xist RNA-associated chro-
matin domains independently of PRC2 (da Rocha et al., 2014).
Jarid2 also binds to other non-coding RNAs in ESCs (Kaneko
et al., 2014) and has been shown to bind nucleosomes directly
(Son et al., 2013). These findings suggest that Jarid2 may have
multiple functions in pluripotent ESCs and could act as an inter-
mediate in the chromatin events that occur as pluripotent cells
move toward differentiation (da Rocha et al., 2014). Consistent
with this view, Jarid2-null ESCs grow and self-renew robustly
in culture but are severely compromised in their capacity to
generate mesoderm, endoderm, or ectoderm lineages in vitro
(Landeira et al., 2010; Shen et al., 2009). In vivo, Jarid2-null
mouse embryos develop normally until E10.5 or beyond (Jung
et al., 2005; Takeuchi et al., 2006), suggesting that Jarid2-null
ESCs may be capable of differentiation but fail to do so in stan-
dard in vitro cultures.
Here, we examined the properties of Jarid2-null ESCs derived
from different sources, as well as the factors that were consis-
tently de-regulated in these cells. Our results show that Jarid2-
null ESCs express constitutively high levels of Nanog proteins,
indicative of a ‘‘naive pluripotent state,’’ together with dramati-
cally reduced planar cell polarity (PCP) and Wnt signaling com-
ponents. In particular, expression of Prickle1, Fzd2, Wnt9a,
E-cadherin, and b-catenin activity were all reduced in Jarid2-
null ESCs, while Wnt antagonists such as Sfrp1 were upregu-
lated. Remarkably, this inverse correlation between PCP/Wnt
signaling and Nanog expression was replicated in wild-type
ESCs depleted ofPrickle1/Fzd2/Wnt9a, or engineered to overex-
press Nanog. Co-culture of Jarid2-null ESCs with wild-type part-
ners allowed the mutant cells to regain variable Nanog expres-
sion and b-catenin activity and restored their capability for
differentiation. Surprisingly, we showed that disruption of PCP/
Wnt signaling early in mouse embryogenesis, by introducing
Jarid2-null ESCs (but not Eed-null ESCs), resulted in multiple
ICM formation. This emphasizes the importance of the Jarid2-
Nanog-PCP/Wnt core circuit for normal development and re-
vealed a non-canonical (PRC2-independent) role for Jarid2 in
coordinating this process.
RESULTS
Jarid2 Affects Nanog Expression in ESCs Maintained
in Serum and Leukemia-Inhibitory Factor
Pluripotency factor expression by ESCs has been generally
assumed to be unaffected by deletion of PRC2 (Azuara et al.,
2006; Boyer et al., 2006; Lee et al., 2006; Pasini et al., 2007;
Shen et al., 2008). Consistent with this, Jarid2-null ESCs (Land-
eira et al., 2010) expressed substantial levels of each of the core574 Cell Reports 12, 573–586, July 28, 2015 ª2015 The Authorspluripotency factors Oct4, Sox2, and Nanog as indicated by
western blotting analysis (Figure 1A, clones E4 and E8). Surpris-
ingly, however, we detected an inverse correlation between
Jarid2 gene dose and Nanog expression [JM8(wild-type) <
A08(+/) < E4(/) and E8(/), Figure 1A]. At the single-cell level,
immuno-labeling for Nanog followed by fluorescence micro-
scopy (Figure 1B) or flow cytometry analysis (Figure 1C) revealed
that the increased expression of Nanog by Jarid2-null ESCs was
due to a reduced proportion of Nanog-low cells. Specifically,
Jarid2-null ESCs appeared homogenously Nanog-high (Fig-
ure 1B, lower panel shows Nanoggreen labeling of virtually all
Oct4blue cells), whereas Nanog-high and -low cells were easily
discerned among parental wild-type JM8 ESCs (upper panel).
This difference was confirmed by flow cytometry (compare
green and gray traces, Figure 1C) where mutant E8 cells showed
a reduced proportion of Nanog-low cells. To verify that altered
Nanog expression was due to Jarid2 depletion rather than simply
clonal variation between different ESC lines, we examined the
properties Jarid2 mutant cells that had been independently
generated by others (Shen et al., 2009). These Jarid2-null(/)
ESCs also expressed constitutively high levels of Nanog protein
detected bywestern blotting (Figure 1D), fluorescence-activated
cell sorting (FACS) analysis (Figure 1E, 82% Nanog-high), and
immunofluorescence microscopy (Figure 1F) (lower-right panel),
as compared to matched wild-type controls (Jarid2 fl/fl). In addi-
tion, we noticed that, among cells plated at low density, Jarid2-
null ESCs failed to properly self-organize into coherent colonies
appearing as either ‘‘spread’’ (such as E8) or ‘‘disorganized’’
overlapping layers of Nanog-high cells (white arrows). To quan-
tify such defects, we assessed the nuclear shape and dimen-
sions of four to eight cell colonies that arose after plating E8
and JM8 ESCs at limiting dilution (Figure S1A). This unbiased
comparison confirmed a profound difference in the nuclear
height/width ratios of cells occupying central and peripheral
positions within Jarid2-null colonies (Figures S1B and S1C).
Taken together, these data suggest that Jarid2 has a role in regu-
lating both Nanog levels and cell-cell interactions in ESCs.
Prior studies of ESCs lacking PRC1 (Ring1B) or PRC2 (Eed)
components have shown similar levels of Nanog and Oct4 as
matched controls (Eskeland et al., 2010; Leeb et al., 2010) sug-
gesting that the effect of Jarid2 depletion on Nanog expression
might not be mediated by PRC2. Furthermore, as Jarid2 does
not directly bind to the Nanog promoter in mouse ESCs (Pasini
et al., 2010), we investigated whether other repressors might
be responsible for regulating Nanog expression differentially be-
tween Jarid2-null and wild-type ESCs. Chromatin immunopre-
cipitation (ChIP) analysis revealed that, although both cell lines
expressed similar levels of Tcf3 (Figure S1D), wild-type ESCs
showed a significant enrichment for Tcf3 bound to a consensus
site in the Nanog promoter, as compared to Jarid2-null samples
(Figure S1E). This result was consistent with Tcf3 mediating the
repression of Nanog in ESCs (Cole et al., 2008) and suggests that
Jarid2 may modulate Tcf3 activity.
Jarid2 Regulates Non-canonical Wnt Signaling
in Undifferentiated ESCs
Tcf3 is a critical component of canonical Wnt signaling pathways
that is implicated in regulating the balance between stem cell
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Figure 1. Jarid2-Null ESCs Express Constitutively High Levels of Nanog Protein
(A) Western blot analysis of whole-cell extracts showing Nanog, Oct4, and Sox2 levels in wild-type (JM8+/+), Jarid2 heterozygous (A08+/–), and two Jarid2
knockout ESC lines (E4–/– and E8–/–). Lamin B provides a loading control.
(B) Confocal images of Nanog (green) and Oct4 (blue) immunofluorescent labeling of wild-type (JM8+/+) and Jarid2-null (E8–/–) ESC cultures. Scale bar, 100 mm.
(C) FACS analysis of Nanog expression by JM8 (+/+, upper) and E8 (–/–, lower) ESCs. Histograms (right) show Nanog detection in JM8 (filled gray) and E8–/– (green)
cultures in which labeling using an isotype control is shown as a black line.
(D) Western blot analysis of whole-cell extracts comparing Nanog and Oct4 protein levels in Jarid2 fl/fl and Jarid2–/– ESCs lines (Shen et al., 2009). Lamin B
provides a loading control.
(E) Comparison of Nanog expression among Jarid2 fl/fl and Jarid2/ ESCs evaluated by flow cytometry. FACS plots (left) and histograms (right) show Nanog
detection in wild-type (Jarid2 fl/fl, filled gray) and Jarid2-null ESC lines (Jarid2–/–, green).
(F) Representative confocal images of colonies of wild-type (JM8+/+, Jarid2 fl/fl) and Jarid2-null (E8–/–, Jarid2–/–) ESCs, plated at low density where Nanog labeling
(green) and DAPI stain (blue) are shown. White arrows show characteristic layers or ‘‘stacks’’ of Nanog-high cells in Jarid2–/– colonies. Scale bar, 10 mm.
See also Figure S1.self-renewal and differentiation. Mouse ESCs maintained in me-
dia supplemented with inhibitors of glycogen synthase kinase 3
and Fgf-MAPK (2i) have elevated Nanog levels (Wray et al., 2010;
Ying et al., 2008) and, like Jarid2-null ESCs, are less prone to dif-
ferentiation. To discover genes downstream of Jarid2, we exam-ined publically available gene-expression microarray data for
Jarid2/ ESCs (Shen et al., 2009) and found that among the
413 genes misregulated relative to controls (fold change > 2,
p value < 0.05) many have roles in cell adhesion, the cytoskel-
eton, and extracellular matrix or are implicated in developmentCell Reports 12, 573–586, July 28, 2015 ª2015 The Authors 575
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(Figure S2A). We examined published ChIP sequencing (ChIP-
seq) data for Jarid2 binding in undifferentiated ESCs (Pasini
et al., 2010) to uncover which genes might be directly regulated
by Jarid2. Among the 1,146 genic promoters enriched for Jarid2
binding, we noticed a strong preference for genes critical in Wnt
signaling (29 genes) and Wnt-related pathways (Figure S2B). To
explore this further, gene-expression profiling was performed to
formally determine whether genes involved in Wnt signaling
pathways were substantially deregulated in ESCs lacking Jarid2.
For this, ESC clones that lacked Jarid2 (E8 and Jarid2/ cells)
were compared with wild-type ESCs (JM8 and Jarid2 fl/fl), and
mRNA expression of Wnt signaling components was quantified
by qPCR using commercially available PCR plates. Among the
candidates showing significant de-regulation in ESCs lacking
Jarid2 (p < 0.05) were Prickle1, Fzd2, Wisp1, Wnt9a, and Fosl1
(downregulated, Figure 2A, left) and Aes, Dkk1, Sfrp1, and
Wnt11 (upregulated, Figure 2A, right). These candidates
included genes with binding sites for Jarid2 within their pro-
moters (Prickle, Fzd2, Fosl1, Wnt9a, Wnt11, Dkk1, and Sfrp1,
Figure S2C) as reported previously (Peng et al., 2009). Careful
pairwise comparison of gene-expression levels relative to
matched parental controls verified a significant up- or downre-
gulation of these genes in Jarid2-null ESCs (Figure 2B, where
black bars show wild-type and white bars indicate Jarid2 nulls).
Differences between the two sources of Jarid2-deficient ESCs
were apparent only for Dkk1, where expression appears particu-
larly sensitive to cell density (data not shown). Fzd2 and Prickle1
are both well-established core components of the non-canonical
Wnt, or PCP pathway in mammals, Wnt11 is a ligand associated
with PCP (Gray et al., 2011), and Dkk1 and Sfrp1 are secreted
Wnt inhibitors involved in PCP signaling in vertebrates (Caneparo
et al., 2007; Satoh et al., 2008) (as depicted schematically in
Figure 2C).
To check whether Jarid2-null ESCs have defects in planar cell
polarity, we examined the distribution of Prickle1 and Vangl1Figure 2. Jarid2 Regulates a Subset of Planar Cell Polarity and Wnt Sig
(A) qPCR array comparison of gene-expression levels of Wnt signaling genes in
Jarid2mutants (triplicates of E8/ and Jarid2–/–). Gene-expression differences (x
a single gene. Most significantly down- (left, green) or upregulated (right, red) ge
(B) RT-PCR analysis of Wnt signaling genes expressed by wild-type (JM8+/+ black
bymatched wild-type (Jarid2 fl/fl black bars) and Jarid2-null (Jarid2–/– white bars)
the results shown are the mean ± SD of three experiments, where asterisks indic
(C) A simplified scheme of Wnt signaling pathways contributing to cytoskeletal a
(D) Confocal images showing labeling of Prickle1, Vangl1, and E-cadherin (green)
10 mm.
(E) Western blots of whole-cell extracts confirm that Jarid2 is absent from Jarid2
Lamin B provides a loading control; size markers are as indicated.
(F) RT-PCR analysis of Prickle1, Fzd2, and Wnt9a transcript levels in wild-type
controls; results show mean ± SD of three experiments, and asterisks indicate s
(G) Comparison of Nanog expression by Jarid2CRISPR targeted ESCs (clone 3, gree
black line shows labeling by isotype controls.
(H) RT-PCR analysis of Prickle1, Fzd2,Wnt9a transcript levels in wild-type E14 ES
analysis confirmed that both alleles of Prickle1 and Fzd2, and a single allele of Wn
Hmbs, and the mean ± SD of three independent experiments is shown.
(I) Representative confocal images show constitutive Nanog expression (green) an
Wnt9a). Characteristic ‘‘layering’’ of Nanog positive mutant cells is highlighted (wh
Scale bar, 10 mm.
(J) Nanog expression by PCPCRISPR#5 ESCs (green) and wild-type E14 ESCs (filled
black line.
See also Figures S2 and S3.proteins (green) in wild-type and Jarid2-null ESCs using immu-
nofluorescence with previously characterized antisera (Fig-
ure 2D). Both proteins were abundant within the cytoplasm
and nucleus of wild-type ESCs (upper panels), whereas in Jarid2
nulls (E8/) Prickle1 and Vangl1 levels were reduced in nuclei
and there was a paucity of both proteins in the cytoplasm. This
difference was confirmed using quantitative analysis of labeling
intensity (Figure S2D) that showed a significant decrease (5- to
10-fold) in Prickle1 and Vangl1 in the cytoplasm of Jarid2-null
ESCs. E-cadherin labeling was also low in Jarid2-null ESCs
and appeared patchy (Figure 2D, green lower right) as compared
with contiguous labeling of cell boundaries in colonies of wild-
type ESCs (Figure 2D, green upper right). These data highlight
a deficiency of PCP proteins in Jarid2-null ESCs.
To extend this analysis, we generated three additional
Jarid2-null ESC lines, using CRISPR/Cas9 to engineer mutations
into the third exon of Jarid2 (Figures S2E–S2G). Clones were
selected that showed frameshift mutation to both endogenous
Jarid2 alleles (Figure S2G), and western blots confirmed the
absence of detectable Jarid2 proteins (Figure 2E). RT-PCR anal-
ysis showed that Prickle1, Fzd2, and Wnt9a expression was
significantly reduced in each mutant clone relative to parental
ESCs (Figure 2F), and flow cytometry analysis (Figure 2G) indi-
cated a characteristic switch to constitutive Nanog-high expres-
sion (green versus gray trace) as illustrated for a Jarid2CRISPR#3
mutant cells. This extends previous observations made with es-
tablished Jarid2-null lines, indicating that deregulated PCP and
Nanog expression was likely to be a direct consequence of
Jarid2 removal rather secondary effects or adaption to culture.
Using a similar CRISPR/Cas9 approach, we also generated
ESC lines lacking Prickle1, Fzd2, and Wnt9a (Figures S2E–
S2G). Six clones were identified with frameshift mutations in
one or both alleles of each of these genes, and each mutant
cell line showed a switch to constitutive Nanog-high expression
and defects in colony formation (‘‘spread’’ or ‘‘layered’’ cells) thatnaling Genes in ESCs
pooled samples of Jarid2 wild-types (triplicates of JM8+/+ and Jarid2 fl/fl) and
axis) are plotted against statistical significance (y axis), and each dot represents
nes are labeled.
bars) and Jarid2-null (E8–/– white bars) ESCs are shown in the upper panel and
in the lower panel. Actb and Rex1 were used as controls for these analyses, and
ate statistical significance (p < 0.05, Student’s t test).
nd transcriptional changes in cells.
and DAPI (blue) staining in wild-type (JM8+/+) and Jarid2-null (E8–/–). Scale bar,
CRISPR ESC clones 1, 2, and 3, using parental E14 wild-type cells as controls.
E14 ESCs and Jarid2CRISPR clones 1, 2, and 3. Actb and Rex1 were used as
tatistical significance (p < 0.05, Student’s t test).
n) and parental wild-type E14 ESCs (filled gray) evaluated by flow cytometry. A
Cs (wt, black bars) and in PCPCRISPR clone 5 (gray bars) where DNA sequencing
t9a contain frameshift mutations (Figures S2G–S2I). Results were normalized to
d aberrant colony formation by PCPCRISPR#5 ESCs (deficient in Prickle1, Fzd2,
ite arrow), and parental wild-type cells are shown for comparison (DAPI, blue).
gray) was evaluated by flow cytometry, and isotype controls are indicated by a
Cell Reports 12, 573–586, July 28, 2015 ª2015 The Authors 577
A B
JM
8 
+/
+
E
8 
-/-
A
08
 +
/-
Total 
β-cat
LamB
JM
8 
+/
+
E
8 
-/-
A
08
 +
/-
Ja
rid
2 
fl/
fl
Ja
rid
2 
-/-
C
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0
0.2
0.4
0.6
0.8
1
1.2
0
0.05
0.1
0.15
0.2
0.25
0.3
JM
8 
+/
+
E
8 
-/-
Ja
rid
2 
fl/
fl
Ja
rid
2 
-/- wt
P
C
P 
   
   
 #
5
C
R
IS
P
R
Ja
rid
2 
   
   
 #
3
C
R
IS
P
R
β-
ca
t a
ct
iv
ity
 (l
uc
ife
ra
se
)
F
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
Fzd2 Prickle1 Wnt9a
0
2
4
6
8
10
12
14
R
el
at
iv
e 
E
xp
re
ss
io
n 
(/H
m
bs
)
Nanogwt OE
R
el
at
iv
e 
E
xp
re
ss
io
n 
(/H
m
bs
)
wt wt wt wtNanogOE NanogOE NanogOE
β-
ca
t a
ct
iv
ity
 (l
uc
ife
ra
se
)
Nanog
NanogOE
E
Low
12%
Medium
17.1%
High
70.7%
Nanog
0
2
4
6
8
10
12
14
unsorted
N
an
og
N
an
og
lo
w
N
an
og
N
an
og
m
ed
iu
m
N
an
og
N
an
og
hi
gh
0
2
4
6
8
10
12
14
β-
ca
t a
ct
iv
ity
 (l
uc
ife
ra
se
)
β-
ca
t a
ct
iv
ity
 (l
uc
ife
ra
se
)
LamB
Active 
β-catenin
Nanog
C
ou
nt
* * *
*
*
*
*
*
Nanog PCP β-cat activity
G
Jarid2 wt
Jarid2 -/-
D
H
Nanog
PCP
β-cat activity
Figure 3. Sustained b-Catenin Activity and PCP Expression in ESCs Requires Jarid2 and Is Sensitive to Nanog Overexpression
(A) Western blot analysis of whole-cell extracts show similar levels of total b-catenin in wild-type (JM8+/+), Jarid2 heterozygous (A08+/–), and -null (E8–/–) ESCs.
Lamin B provides a loading control.
(B) Western blots of active b-catenin detected in Jarid2-null (E8/, Jarid2/) versus parental ESC lines. Nanog is shown for comparison; Lamin B provides a
loading control.
(C) b-catenin activity, evaluated by luciferase-based TOPFlash assays comparing matched pairs of wild-type (black bars) and Jarid2-null (white bars) ESCs:
JM8:E8 (left), Jarid2 fl/fl: Jarid2/ (middle), wt:Jarid2CRISPR#3 (right). Reduced b-catenin activity was evident in ESCs lacking Prickle1/Fzd2/Wnt9a
(PCPCRISPR#5, gray bar). Mean ± SD of three experiments are shown; asterisks indicate statistical significance (p < 0.05; Student’s t test).
(D) RT-PCR analysis confirm a 7-fold increase in Nanog expression in ESCs engineered to overexpress Nanog (NanogOE, white bar), compared to wild-type
(black bar).
(E) TOPFlash assays show reduced b-catenin activity in NanogOE ESCs (white bar) as compared with wild-type ESCs (wt, black bar). Mean ± SD of three ex-
periments, where asterisks show statistical significance (p < 0.05; Student’s t test).
(F) RT-PCR analysis of Fzd2, Prickle1, andWnt9a transcripts detected in wild-type (black bars) and NanogOE (white bars) ESCs. Mean ± SD of three experiments;
asterisks show statistical significance (p < 0.05; Student’s t test).
(legend continued on next page)
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resembled Jarid2-null ESCs. This is exemplified for PCPCRISPR#5
(Figures 2H–2J), a clone with frameshift mutations in both
endogenous Prickle1 and Fzd2 alleles and a single Wnt9a allele
(Figure S2G). This cell line showed dramatically reduced expres-
sion of all three genes (Figure 2H), expressed Nanog constitu-
tively (Figure 2I, green) (Figure 2J, green trace), and showed
aberrant clonal morphology (Figure 2I, right, arrows). Taken
together, these data showed a hitherto-unrecognized role for
Jarid2 in regulating non-canonical Wnt signaling and Nanog
expression in undifferentiated ESCs.
Although Jarid2 binds to the promoters of Prickle1, Fzd2,
Wnt9a,Wnt11, Dkk1, and Sfrp1 (Pasini et al., 2010) (Figure S2C),
ChIP analysis revealed similar H3K27me3 levels at these targets
in Jarid2-wild-type (JM8), heterozygous (A08), and null ESC lines
(E4, E8) (Figure S3A). This observation, together with the fact that
Prickle1, Fzd2, and Wnt9a expression apparently requires
Jarid2, suggests that Jarid2 may regulate PCP/Wnt signaling in
ESCs in a way that is independent of its canonical role as a
component of PRC2. A comparison of the replication timing of
a panel of genes involved in PCP/Wnt signaling in wild-type
(black bars) and Jarid2-null ESCs (white bars, Figure S3B) also
showed similar temporal profiles, suggesting that the chromatin
structure of these genes was not radically different in the
absence of Jarid2.
b-Catenin Activity Is Reduced in ESCs that Lack Jarid2
or Overexpress Nanog
We examined whether canonical Wnt signaling (b-catenin medi-
ated) was also impaired in ESCs lacking Jarid2. As shown in
Figure 3A, western blots revealed broadly similar amounts of
b-catenin in whole-cell extracts derived from Jarid2-null (E8),
heterozygous (A08), and wild-type ESCs (JM8). However, using
antibody specific for active forms of b-catenin (Figure 3B), we
observed reduced levels of active b-catenin in ESCs lacking
Jarid2 (E8, Jarid2/) compared to wild-type cells (JM8, Jar-
id2fl/fl). This reduction was confirmed in functional assays using
TOPFlash (luciferase-based) reporters. b-catenin activity was
significantly reduced in both established (E8 and Jarid2/)
and newly generated (Jarid2CRISPR#3) Jarid2-null ESCs (Fig-
ure 3C, white bars) compared with controls (black bars), and
also in Prickle1/Fzd2/Wnt9a depleted ESCs (PCPCRISPR#5,
gray bar). Since each of these mutant ESCs also expressed
Nanog constitutively, we asked whether Nanog expression per
se was important for reduced b-catenin activity. ESCs that stably
express elevated levels of Nanog (Figure 3D, NanogOE white
bars) were generated as described previously (Theunissen
et al., 2011). These cells showed significant reductions in b-cat-
enin activity and reduced expression of Fzd2, Prickle1, and
Wnt9a (Figures 3E and 3F), providing compelling evidence of a
robust regulatory circuit between Nanog, PCP and b-catenin ac-
tivity that is sensitive to Jarid2 (illustrated in Figure 3G). Opera-
tionally, this balance between Nanog and Wnt signaling was
also evident in ESCs expressing wild-type levels of Nanog(G) Schematic representation of the interdependency of Nanog, PCP, and active
(H) ESCs carrying a Nanog-GFP reporter (TNG) were used to sort cells expressing
et al., 2007) as shown in the upper panel, and b-catenin activity was compare
comparison. Results show mean ± SD of three independent experiments.(Chambers et al., 2007), where Nanog expression and b-catenin
activity were inversely correlated (Figure 3H).
Jarid2-Null ESCs Have Defects in Cell Sorting and
Differentiation that Can Be Partially Rescued
by Co-culture with Jarid2 Wild-Type ESCs
ESCs lacking Jarid2 grow as ‘‘spread’’ or ‘‘layered’’ colonies that
respond poorly to differentiation cues (Landeira et al., 2010). To
better understand whether defective Wnt signaling in Jarid2-null
ESCs might underlie their inability to form coherent differentia-
tion-responsive colonies, we initiated a series of cell mixing/sort-
ing experiments in which Jarid2-null E8 cells were co-cultured
with wild-type or Jarid2 heterozygous partners. E8 cells express
GFP (Landeira et al., 2010) allowing these cells to be easily
tracked in co-culture. ESCs were mixed in a 1:1 ratio, plated
on gelatin-coated plates, and analyzed 16–24 hr after mixing
(Figure 4A). Jarid2-null ESCs were unable to form tight colonies
when plated alone or with heterozygous (A08) partners (top,
green), but this capacity was restored when mixed with (unla-
beled) wild-type ESCs (Figure 4A, lower image). Co-culture of
E8 cells with wild-type ESCs also resulted in preferential sorting
of mutant cells to the periphery of colonies (Figure 4A, histo-
grams right), similar to the peripheral sorting of Nanog-high cells
seen in wild-type JM8 colonies (Figure 1F). Although co-culture
of E8 and wild-type ESCs increased overall E-cadherin expres-
sion in mixed colonies (Figure S4A, red), a close examination
revealed that E-cadherin expression by mutant cells remained
low in cultures at 16 hr (Figure S4B). These data showed that
Jarid2-null ESCs have intrinsic defects in canonical and non-ca-
nonical Wnt signaling, likely to contribute to aberrant cell-cell
interactions.
Remarkably, co-culture of Jarid2-null (GFP+) ESCs with wild-
type partners resulted in a switch from constitutive Nanog-high
expression (Figure 4B, E8/ left) to a profile that was indistin-
guishable from wild-type ESCs (Figure 4B, E8/ right). Expo-
sure of Jarid2-null ESCs to wild-type ESCs also restored b-cat-
enin activity in the mutant cells (Figure 4C) and improved their
capacity to differentiate (Figures 4D and 4E). Following co-cul-
ture and leukemia-inhibitory factor (LIF) withdrawal, Jarid2-null
E8-derived (GFP) cells expressing neural-associated markers
such as Nestin and Mash1 (red) were readily identified within
mixed cultures (47% of GFP+ cells expressed Nestin). Neural in-
duction was less efficient than in control wild-type cultures
(>80% Nestin positive by day 10, Figure S4C), and fewer cells
were recovered overall (5%–10%). Co-culture of E8 cells with
Jarid2-null ESCs, fibroblasts, T or B cells, or with conditioned
media derived from wild-type ESCs did not rescue the capability
of E8 cells to differentiate (data not shown) or enhance b-catenin
activity in these cells (as shown in Figure S4D). Because b-cate-
nin activity is reportedly required for ESC differentiation (Atlasi
et al., 2013; Lyashenko et al., 2011), Jarid2-null ESCsmay be un-
able to execute differentiation efficiently because of low b-cate-
nin activity. In this scenario, co-culture with wild-type ESCsb-catenin expression in ESCs, revealed through studies of Jarid2 depletion.
high (light gray), medium (gray), or low levels (dark gray) of Nanog (Chambers
d using TOPFlash (lower panel). Unsorted TNG ESCs (black) are shown for
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restores b-catenin activity and may enable mutant ESCs to
differentiate (Figure S4E shows a hypothetical scheme).
Cytoplasmic Prickle1 DistributionMarks the Developing
Epiblast In Vivo
To investigate whether Jarid2 regulation of Nanog PCP/Wnt
signaling is likely to be important in vivo as well as in vitro, we
examined the distribution of Prickle1 in the pre-implantation
mouse embryo. Depletion of PCP components, including
Prickle1, has been reported to lead to defects in cell adhesion
that affect the development of early mouse embryos (Larue
et al., 1994; Na et al., 2007; Tao et al., 2009), and previous
studies have shown that although Prickle1 is detected at E5.5
and earlier (Tao et al., 2009, 2012), canonical Wnt signaling is
operational slightly later in development (Na et al., 2007). We
examined mouse embryos from E3 to E4.5 for Prickle1 expres-
sion using DAPI as a counterstain (blue) to assess cell number.
Immuno-labeling with antibodies to Nanog (red), Oct4 (data not
shown), or Gata6 (red) was used to assess the stage and orien-
tation of the developing inner cell mass (ICM) (Figures 5A and
5B). As illustrated in Figure 5A, Prickle1 (green) was abundantly
detected in 32- and 64-cell embryos and showed a prominent
cytoplasmic distribution in Nanog positive cells destined to
form the epiblast (region outlined in white, Figure 5A). By E4.5,
Nanog-high cells were condensed to the pole of the embryo
where they expressed high levels of Prickle1 distributed equiva-
lently between nuclei and cytoplasm. The surroundingGata6-ex-
pressing cells (red) also expressed high levels of Prickle1 (green),
but in this case expression was predominantly nuclear (Fig-
ure 5B, region highlighted in white). Most cells in the polar tro-
phectoderm showed modest levels of mostly nuclear Prickle1.
An exception was of a small group of two to six mural trophecto-
derm cells, in which Prickle1 expression was high and located in
nuclei and particularly within nucleoli (summarized in the sche-
matic diagram shown in Figure 5C). The selective distribution
of cytoplasmic Prickle1 in cells of the epiblast versus primitive
endoderm or trophectoderm was confirmed in optical sections
of E4.5 embryos as shown in Figure S5A (green labeling and
traces). E-cadherin (red, Figure 5D) was prominent throughout
the blastocyst at these stages.
Jarid2-Null ESCs Initiate Multiple ICMs upon Injection
into Normal Blastocysts
ESCs that lack Jarid2 expressed high levels of Nanog and low
levels of Prickle1, Vangl1, and b-catenin activity and showFigure 4. Differentiation of Jarid2-Null ESCs Is Restored following Co-
(A) Cell mixing experiments were designed to analyze the cell-cell sorting prope
show GFP-marked Jarid2-null ESCs (E8/, green) 16 hr after being cultured alo
Histograms (right) show the proportion of colonies where Jarid2-null cells sort to
(B) FACS analysis of Nanog expression by JM8 and E8 cells before mixing (left),
(C) Histograms show b-catenin activity evaluated using TOPFlash in GFP-sorted
72 hr (white bars). b-catenin activity in JM8 cells provides a control (black bar).
nificance (p < 0.05; Student’s t test).
(D and E) Confocal images showing Nestin (D) or Mash1 (E) immuno-labeling (re
culture with wild-type (JM8-unlabelled) ESCs and differentiation. DAPI stain (blue
labeled E8-derived cells at this time, whereas very few viable E8 cells were reco
(Landeira et al., 2010). Scale bars, 20 mm (Nestin), 10 mm (Mash1).
See also Figure S4.severely compromised differentiation (Landeira et al., 2010). As
these defects were partially compensated by in vitro co-culture
with wild-type ESCs, we asked towhat extentmutant cells would
contribute to the developing embryo. Wild-type E3.5 blastocysts
were injected with either 10–15 GFP+Jarid2-null ESCs (E8) or an
identical number of GFP-labeled wild-type ESCs (JM8) and then
were cultured for 16–20 hr before being examined. Remarkably,
we found that blastocysts injected with Jarid2-null ESCs
routinely initiated the formation of more than a single ICM (16/
39, illustrated in Figure 5E, lower panels), a feature that was
not detected in any of the controls injected with wild-type
ESCs (0/90, upper panels). Importantly, although these second-
ary ICMs appeared to be focused around small clusters of
Jarid2-null ESCs (marked in green), in which higher levels of
Nanog might be anticipated, Gata6 expression (red) was
induced in the underlying wild-type cells (Figure 5F). This sug-
gested that injection the mutant ESCs was sufficient to instruct
neighboring wild-type blastomeres to upregulate Gata6 and
thus contribute to the formation of multiple ICMs. To distinguish
whethermultiple ICM formationwas due to defective PRC2 func-
tion, or defective Nanog, PCP, and Wnt circuitry, we injected
E3.5 blastocysts with ESCs lacking Prickle1/Fzd2/Wnt9a, over-
expressing Nanog, or that lacked Eed (Azuara et al., 2006) a
core component of the PRC2 complex. As shown in Table 1,
injection of wild-type (E14) and Eed-deficient (B1.3) ESCs
generated only a single ICM in multiple experiments, whereas
blastocysts injected with equivalent numbers of Jarid2-null
(Jarid2CRISPR#3), Prickle1/Fzd2/Wnt9a-depleted (PCPCRISPR#5),
or NanogOE-overexpressing ESCs formed multiple ICMs in
approximately 35%–48% of samples.
DISCUSSION
Our studies reveal several important and unanticipated results.
First, we show that Jarid2, a Polycomb group member impli-
cated in PRC2 recruitment, chromatin structure, and gene
repression, acts as a positive regulator of PCP/Wnt signaling
pathways in ESCs. Absence of Jarid2 or depletion of Prickle1/
Fzd2/Wnt9a results in constitutive Nanog expression by ESC,
which, in turn, results in reduced levels of active b-catenin. These
observations identify an important Jarid2-sensitive core circuit in
ESCs that regulates pluripotency and differentiation. In previous
studies, Jarid2-null ESCs were shown to have a profoundly
compromised ability to differentiate in culture (Landeira et al.,
2010; Li et al., 2010; Pasini et al., 2010; Peng et al., 2009; Shenculture with Wild-Type ESCs
rties of Jarid2-null ESCs (left). Confocal immunofluorescence images (middle)
ne or mixed in a 1:1 ratio with GFP-negative A08 (Jarid2+/) or JM8 (Jarid2+/+).
the periphery of mixed colonies. Scale bar, 10 mm.
and by E8/ cells (GFP sorted) 24 hr after co-culture with wild-type ESCs.
E8 ESCs before and after co-culture with wild-type ESCs (1:3 ratio) for 24 and
Results show mean and SE of three replicates; asterisks show statistical sig-
d) of GFP-labeled E8-derived cells (Jarid2 null, green) at 10–12 days after co-
). Scale bar, 10 mm. Nestin positive cells accounted for 47% of the total GFP-
vered in parallel ‘‘unmixed’’ cultures, and Nestin expression was not detected
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Table 1. Multiple ICMs are Induced in E3.5 Mouse Blastocysts
Injected with Jarid2-Null, Prickle1/Fzd2/Wnt9a-Depleted, or
Nanog-Overexpressing ESCs
ESC
Number of Blastocysts
Injected/Analyzed
Number of Blastocysts
with >1 ICM (%)
JM8+/+ 90 0
E8–/– 39 16 (41)
E14 62 0
Jarid2CRISPR#3 40 14 (35)
PCPCRISPR#5 23 11 (48)
Nanog-OE 43 19 (44)
Eed-deficient B1.3 27 0et al., 2009). Here, we show that canonical and non-canonical
Wnt signaling is reduced in Jarid2-null ESCs, and these cells
are unable to establish coherent colonies with each other. Intro-
duction of wild-type ESCs supports the formation of colonies
and increases b-catenin activity within Jarid2-null ESCs, allow-
ing them to properly execute differentiation programs in
response to appropriate cues, although the nature of the support
offered by wild-type ESCs is at present unclear.
These results are perhaps surprising in view of reports impli-
cating Jarid2 in the regulation of Notch1 (Mysliwiec et al.,
2011), or showing that Nanog represses the expression of
Dkk1 (a secreted Wnt inhibitor) in ESCs to enhance b-catenin
expression (Marucci et al., 2014). Current literature contains
many conflicting reports on whether b-catenin is essential or
dispensable for maintaining ESC pluripotency (Okumura et al.,
2013; Soncin et al., 2009; ten Berge et al., 2011; Wray et al.,
2011; Ying et al., 2008). This discrepancy probably reflects the
fact that b-catenin is pleotropic and regulates both gene tran-
scription and cell adhesion (reviewed in Brembeck et al., 2006
and Heuberger and Birchmeier, 2010). In addition, the require-
ment for and effects of b-catenin appear to be context depen-
dent (Lyashenko et al., 2011; Okumura et al., 2013; Wray et al.,
2011; Yi et al., 2008) and are reported to differ between naive
and primed ESCs (Kurek et al., 2015; ten Berge et al., 2011).
Our data show that Jarid2-null ESCs maintained in LIF and
serum have low b-catenin activity despite unchanged levels of
total protein. These cells can self-renew but have an impaired
capacity to differentiate. Co-culture ofmutant cells both restored
b-catenin activity and allowed them to differentiate, consistent
with several reports showing that nuclear b-catenin is required
to execute differentiation in vitro (Atlasi et al., 2013; Lyashenko
et al., 2011) and in vivo (Haegel et al., 1995; Huelsken et al.,
2000).
Previous studies have shown that non-canonicalWnt signaling
is present in mouse blastocyst before implantation (Tao et al.,
2009, 2012). Early blastomeres express cytoplasmic Dishevelled
(Dvl) proteins but may not activate canonical Wnt signaling as
judged by sensitive BAT-gal Wnt reporters (Na et al., 2007).
Overexpression of Dvl, a downstream target of Prickle1, Vangl,
and Frizzled (Fz) (Go´mez-Orte et al., 2013; Lape´bie et al.,
2011), has been shown to dramatically alter the morphology
and adhesion properties of 4-cell stage mouse embryos, result-
ing in a lack of coherence in the resulting blastocyst (Na et al.,Figure 5. ESCs Lacking Jarid2 Induce the Formation of Multiple ICMs
(A) Confocal immunofluorescence images show mouse blastocysts at 32-cell (le
immuno-labeled for Nanog (red), Prickle1 (green), and DAPI stain (blue). The dot
(E4.5), indicated by high Nanog levels. Scale bar, 10 mm.
(B) Representative confocal images show Gata6 (red), Prickle1 (green) labeling,
primitive endoderm as defined by high Gata6 expression.
(C) Schematic summary of Nanog, Gata6, and Prickle1 distribution in E4.5 blasto
(D) Representative confocal image of a E4.5 blastocyst labeled for E-cadherin (r
(E) Representative confocal images of wild-type blastocysts that were labeled for
labeled wild-type (JM8) ESCs (upper panels) or GFP-labeled Jarid2-null (E8) ESC
type ESCs, whereas multiple ICMs were detected in ten of 24 and six of 15 blas
dotted lines indicate the Nanog-high compartment corresponding to the develop
(F) Confocal image of E4.5 blastocyst after injection of GFP-labeled E8 cells (green
10 mm.
See also Figure S5.2007). Likewise, deletion of Prickle1 in mouse embryos results
in local disorganization of epiblast tissue (Tao et al., 2009) and
early embryonic death (E5.5–E6.6), while lower levels of Wnt9a
promotes cell proliferation (Xiang et al., 2008). Here, we show
that PCP expression is reduced in Jarid2-null ESCs, and their
introduction into E3.5 blastocysts induces the formation of mul-
tiple ICMs in around half of the embryos. CanonicalWnt signaling
is thought to begin at implantation in the mouse (Na et al., 2007),
and it is tempting to speculate that the group of cells in the mural
trophectoderm identified by high levels of Prickle1 in nucleoli
may be cells destined to mediate implantation into the uterus.
Whatever the explanation, our demonstration that wild-type cells
can rescue the differentiation of Jarid2-null ESCs in vitro may
provide important insights for understanding the conflicting dif-
ferentiation status of Jarid2 cells in vivo and in vitro. In homoge-
nous clonally derived cultures, mutant cells are unable to estab-
lish bona fide cell-cell interactions or enhance b-catenin activity,
whereas in heterogenous cultures (with wild-type ESC partners)
or in vivo (with other blastocyst-derived cells) b-catenin activity
and PCP/Wnt signaling may be partially compensated.
Our discovery that Jarid2 is a regulator of PCP/Wnt is also
important for re-evaluating some of the emerging evidence that
Jarid2mutations (or SNPs) are risk factors for several human dis-
eases. Genetic studies have for example linked Jarid2 with non-
syndromic cleft lip (Scapoli et al., 2010). In mice, Jarid2 is highly
expressed in epithelial cells and in themerging palatal shelves. In
this context, as well as in congenital heart defects where Jarid2
mutations have also been reported (Volcik et al., 2004), theupon Injection into E3.5 Mouse Blastocysts
ft panel), 64-cell (middle panel), or E4.5 (right panel) stages of development,
ted white line highlights the inner cell mass (32- and 64-cell stage), or epiblast
and DAPI staining (blue) of E4.5 blastocysts. The dotted white line marks the
cysts.
ed), Prickle1 (green), and DAPI (blue) stain. Scale bar, 10 mm.
Nanog (red) at E4.5, that had been previously injected (E3.5) with ten to 15 GFP
s (lower panels). A single ICM was detected all (90) samples injected with wild-
tocysts injected with Jarid2-null ESCs in two independent experiments. White
ing epiblast. Scale bar, 10 mm.
) (as in E) showing induction of Gata6 (red) in adjacent wild-type cells. Scale bar,
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potential for Jarid2 mutations to de-regulate PCP/Wnt signaling
might be very informative for understanding the molecular basis
of these malformations and could potentially offer different op-
portunities for intervention. In the case of cancer, Jarid2 muta-
tions have been linked to metastases at diagnosis in soft-tissue
sarcoma (Walters et al., 2014), to non-small cell lung carcinoma
(Manceau et al., 2013), T-ALL, and to myeloproliferative disease
(Saunthararajah and Maciejewski, 2012). Although it is possible
that Jarid2 has an impact on these diseases based on its canon-
ical role in PRC2-mediated chromatin modulation, it is also
possible that Jarid2 is more directly involved in metastatic pro-
gression through its potential impact on cell sorting, cellular
adhesion, and PCP/Wnt signaling. Thus, in addition to influ-
encing PRC2 recruitment and H3K27 HMTase activity in ESCs,
we have shown that Jarid2 is necessary to maintain a balance
between Nanog expression and PCP/Wnt/b-catenin in ESCs
that is essential to enable them to properly respond to differen-
tiation cues. Regulation of this core circuit is also critical for
normal pre-implantation development, since it appears to enable
clusters of developing blastocysts to be discriminated and form
a single inner cell mass. The discovery that Jarid2 regulates
PCP/Wnt signaling in addition to its canonical role in PRC2 high-
lights an important intersection between cell signaling and chro-
matin-based regulation, relevant for understanding the interplay
between pluripotency and differentiation.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are available in the Supplemental Experi-
mental Procedures.
Mouse ESC Culture
ESC lines were grown using standard conditions on 0.1% gelatin-coated
dishes in the presence of LIF and 10% fetal calf serum. Neural differentiation
was carried out as described previously (Conti et al., 2005).
Wnt Signaling Pathway and Gene-Expression Analysis
Analysis of Wnt signaling pathway genes was performed using SYBR Green
PCR array RT2 profiler (SABioscience). Gene-expression analysis by RT-
qPCR using SYBR Green (QIAGEN) was performed as previously described
(Landeira et al., 2010).
Western Blot, Immunofluorescence, and Flow Cytometry Analysis
Western blots were carried out using the following antibodies: mouse antisera
to total b-catenin (BD Biosciences) and active b-catenin (Millipore), rabbit
antisera to Nanog (Cosmo Bio), Jarid2 (Abcam), and goat antisera to Oct4
(Santa Cruz Biotechnology), Sox2 (Santa Cruz), Tcf3 (Santa Cruz), and Lamin
B (Santa Cruz). Immunofluorescence analyses of ESC colonies and mouse
blastocysts were carried out using the following primary antibodies: mouse
antibodies against Oct4 (BD), E-cadherin (BD), Mash1 (BD); rabbit antisera
against Nanog (Cosmo Bio), Vangl1 (Sigma), and Prickle1 (gift from A.G. Bas-
suk) (Bassuk et al., 2008); and goat antisera against Gata6 (R&D Systems) and
Nestin (Santa Cruz). Flow cytometry analysis of Nanog expression was carried
out as previously described (Festuccia and Chambers, 2011) with the following
modifications: 23 10E5 cells were stained using rabbit antisera against Nanog
(2.5 mg/ml, Cosmo Bio) and anti-rabbit conjugated to Alexa 647 (6 mg/ml, Mo-
lecular Probes).
Injections of ESCs into Mouse Blastocysts
10 to 15 GFP-expressing ESCs were injected in the inner cell mass of C57BL/6
blastocysts at E3.5. Injected embryos were cultured for 16 hr in KSOM media
after which they were fixed for immunofluorescence analysis.584 Cell Reports 12, 573–586, July 28, 2015 ª2015 The AuthorsCRISPR/Cas9-Mediated Genome Editing
Single-guide RNA sequences were cloned into human codon optimized
SpCas9 and chimeric guide RNA expressing px330 plasmid (Cong et al.,
2013) followed by co-transfection into ESCs. Individual ESC clones were
picked and sequenced to identify mutations.
TOPFlash Assays
Cells (106 per well) were transfected with 1 mg TOPFlash and 0.1 mg Renilla
luciferase plasmids in 6-well plates using Lipofectamine 2000 reagent (Life
Technologies) and analyzed using the Dual Luciferase Reporter Assay System
(Promega).
Tcf3 and H3K27me3 ChIP Analyses
23 107 ESCswere crosslinked using 1% formaldehyde. Tcf3 ChIPwas carried
out as described previously (Cole et al., 2008). H3K27me3 ChIP was carried
out as described previously (Landeira et al., 2010).
Animal Procedures
Animals used in the study were maintained and handled according to the
guidelines of the Imperial College Animal Welfare Ethical Review Committee
and the regulations set out by the British Home Office.
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